News

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...
U.S. President Donald Trump listens to remarks during a swearing-in ceremony for Administrator of the Centers for Medicare ...
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...
Minnesota Gov. Tim Walz declared Wednesday "Medicaid and Medicare Day," and marked the day by discussing the anticipated ...
An estimated 4.4% of primary care physicians left Medicare in 2023 — a higher exit rate than specialists — according to a new ...
In 1965, President Lyndon B. Johnson signed Medicare into law, dedicating it to former President Harry Truman, who "planted ...
Medicare is on shaky ground in the current policy environment, making it difficult to sustain its accomplishments, much less ...
The federal government's Medicare program and older adults together spend $4.4 billion a year on care that has low clinical ...
Thousands of Rhode Island seniors and disabled residents no longer covered for non-emergency visits at four local hospitals ...
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...